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Abstract
Human metapneumovirus (hMPV) is a major cause of lower respiratory tract infections (LRTIs) in infants, elderly and immunocompromised
patients. In this study, we show that hMPV can infect in a similar manner epithelial cells representative of different tracts of the airways. hMPV-
induced expression of chemokines IL-8 and RANTES in primary small alveolar epithelial cells (SAE) and in a human alveolar type II-like
epithelial cell line (A549) was similar, suggesting that A549 cells can be used as a model to study lower airway epithelial cell responses to hMPV
infection. A549 secreted a variety of CXC and CC chemokines, cytokines and type I interferons, following hMPV infection. hMPV was also a
strong inducer of transcription factors belonging to nuclear factor (NF)-κB, interferon regulatory factors (IRFs) and signal transducers and
activators of transcription (STATs) families, which are known to orchestrate the expression of inflammatory and immunomodulatory mediators.
© 2007 Elsevier Inc. All rights reserved.Keywords: hMPV; Airway epithelial cells; Chemokines; Inflammation; Transcription factorsIntroduction
Human metapneumovirus (hMPV), first identified from
children with respiratory symptoms in 2001, is a significant
respiratory pathogen worldwide (van den Hoogen et al., 2001;
Falsey et al., 2003; Kahn, 2006). hMPVis amember of the genus
Metapneumovirus of the family Paramyxoviridae, based on
genomic sequence analysis and organization (van den Hoogen et
al., 2002). Studies have shown that hMPV infects ∼46% of
children b1 year, ∼70% of children by the time of age 5 and
virtually all children by the ages of 5–10 (Principi et al., 2006;
Williams et al., 2004). hMPVaccounts for not only 10–15% of
pediatrics hospitalization but also for 10% of all hospitalizations
of elderly patients with respiratory tract infections (Falsey et al.,
2003). Furthermore, hMPV is a significant cause of morbidity
andmortality in immunocompromised patients and patients with
chronic obstructive pulmonary disease (van den Hoogen et al.,
2003; Debiaggi et al., 2006; Dare et al., 2007).⁎ Corresponding author. Department of Pediatrics, Division of Child Health
Research Center, 301 University Blvd., Galveston, TX 77555-0366, USA. Fax:
+1 409 772 1761.
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doi:10.1016/j.virol.2007.06.023hMPV-induced clinical illnesses range from mild upper
respiratory tract infections to severe bronchiolitis and pneumo-
nia (van den Hoogen et al., 2003). Investigations done in animal
models of infection have shown that hMPV infection induced
important pulmonary inflammation, characterized by alveolitis,
interstitial inflammation and increased peribronchiolitis
(Alvarez et al., 2004; Hamelin et al., 2005; Wyde et al., 2005;
Williams et al., 2005). Although hMPV shares similar epide-
miological and clinical features with RSV (Principi et al., 2006;
Williams et al., 2006), we and others have shown that they
induce a different spectrum of cytokines and chemokines both in
vitro, using dendritic cells, and in vivo, either in a mouse model
of infection or in children, suggesting a different ability of these
two viruses to induce cellular responses (Guerrero-Plata et al.,
2006, 2005a,b; Jartti et al., 2002; Laham et al., 2004).
Similar to RSV, airway epithelial cells are the primary target
of hMPV infection (Biacchesi et al., 2006; Alvarez et al., 2004).
However, little is known of their response to hMPV infection. In
this study, we show that hMPV could infect and replicate
similarly in epithelial cells from various tracts of the airways.
hMPV infection of primary small alveolar epithelial cells (SAE)
or of an alveolar type II-like epithelial cell line (A549) induced
similar expression of the chemokines RANTES and IL-8,
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the interaction of hMPV with lower airway epithelial cells,
similar to what we have previously shown for RSV infection
(Zhang et al., 2001). We then determined whether hMPV
induced the production of other inflammatory/immunomodula-
tory mediators. We found that A549 cells secreted a variety of
cytokines and chemokines upon hMPV stimulation. Since
activation of transcription factors belonging to the NF-κB and
IRF families is critical for the expression of many cytokines and
chemokines (Siebenlist et al., 1994; Taniguchi et al., 2001;
Barnes et al., 2002), we also investigated the ability of hMPV to
induce their nuclear translocation and DNA binding to IL-8 and
RANTES promoter binding sites. Our results show that hMPV
was a strong inducer of p50 and p65, which are members of the
NF-κB families, as well as of IRF-1, -3 and -7. Finally, we
investigated the ability of hMPV to induce type I interferons and
to activate IFN-dependent signaling molecules. hMPV-infected
A549 cells secreted significant amounts of both IFN-α and IFN-
β. In addition, STAT1, STA2 and IRF-9, which form the
intracellular ISGF3 complex necessary to induce antiviral genes
(Martinez-Moczygemba et al., 1997), were strongly activated
following infection with hMPV.
Results
hMPV replication in epithelial cells
hMPV is a recently identified respiratory virus and there is
limited knowledge of the response of airway epithelial cells, the
target of infection, to this virus. Here, we used normal bronchial
epithelial cells (NHBE), SAE and A549 cells, which represent
cells from bronchial, terminal bronchioli and alveolar type II-like
epithelial cells, respectively, to determine whether hMPV
replicates similarly in cells from different tract of the airways.
Cells were infected with hMPV at MOI of 3 and viral presence
was analyzed by immunofluorescence, using an anti-hMPV
polyclonal antibody, at 48 h post-infection (p.i.). Infected cells
showed typical intracytoplasmic fluorescent granular inclusions
when stained with the specific antibody, but not with isotope
control (Fig. 1). Similarly, uninfected cells did not show granular
stainingwith either antibody (data not shown). For each cell type,
several pictures were taken and the percentage of cells which
showed hMPV staining was counted over the total number of
cells examined. All three cell types showed a similar percentage
of infection, which range from 80 to 90% (data not shown).
We then investigated hMPV ability to replicate in NHBE,
SAE and A549 cells. Cells were infected at MOI of 0.1, viral
inoculum was removed after 1 h of incubation, and cells were
harvested at 72 h p.i. to determine viral titer. LLC-MK2 cells,
the cell line used to propagate hMPV, were used for comparison.
We could not investigate viral replication at later time points of
infections, above 72 h p.i., because there was a significant cell
death in NHBE and SAE, compared to A549 cells, likely due to
the absence of serum required for the infection. We found that,
although hMPV replication in NHBE, SAE and A549 was a log
less than in LLC-MK2 cells, viral titers among the different
airway epithelial cells were very similar (Table 1), indicatingthat they are equally permissive to hMPV infection. On the
other hand, there was no detectable replication of hMPV
following inactivation with UV light (data not shown).
A549 and SAE cells secrete similar mediators following hMPV
infection
IL-8 and RANTES are prototypes of CXC and CC chemo-
kines, respectively (Miller and Krangel, 1992). To determine
whether A549 and SAE cells secreted similar mediators
following hMPV infection, supernatants from control or
hMPV-infected cells were harvested at different time points of
infection to measure IL-8 and RANTES protein by ELISA. As
shown in Fig. 2A, hMPV infection induced a similar pattern of
IL-8 secretion in both A549 and SAE cells, with induction
starting from 6 h p.i. For RANTES, we found that there was a
slight delayed kinetic of RANTES production in SAE cells (Fig.
2B), compared to A549 cells, similar to what we have
previously shown for RSV infection (Zhang et al., 2001).
To determine whether chemokine induction in epithelial cells
in response to hMPV infection was dependent on viral
replication, A549 cells were infected with either live or UV-
inactivated virus. At 24 h p.i. cell supernatants were harvested
to measure RANTES and IL-8 as described above. Only A549
cells infected with live hMPV released significant amounts of
both chemokines, while UV-inactivated hMPV failed to do so
(data not shown), indicating that chemokine secretion by hMPV
requires viral replication.
A549 cells secrete multiple proinflammatory mediators upon
hMPV infection
Cytokines and chemokines secreted by airway epithelial
cells play a critical role in initiating and modulating pulmonary
inflammation upon viral infections. Chemokines are small
proteins that control cellular migration at the site of infection
and their family in mammals contains nearly 50 members.
Depending on the arrangement of the first two N-terminal
cysteines, chemokines are divided into four subfamilies: CXC,
CC, C and CX3C (Baggiolini et al., 1997). The CXC subfamily
is further divided in two groups, based on the absence or
presence of three specific amino acids (Glu–Leu–Arg), which
form the ELR motif (Baggiolini et al., 1997). To further
investigate the pattern of inflammatory/immune mediators
secreted by airway epithelial cells in response to hMPV
infection, we used multibead array system, which detects a
panel of 24 different cytokines and chemokines. A549 cells
were infected with hMPV, MOI of 3, for 6, 12, 24 and 48 h and
then harvested to collect cell culture supernatants. We did not
detect secretion of IL-1β, IL-2, IL-4, L-5, IL-7, IL-10, IL-12
(p70), IL-13, IL-15, IL-17, TNF-α and IFN-γ by A549 cells
following hMPV infection, while we confirmed increased
secretion of IL-8 and RANTES, as well as other CXC and CC
chemokines (Fig. 3). IL-6 was the only cytokine significantly
induced by hMPV infection (Fig. 3D). Among the CXC
chemokines, hMPV induced secretion of IP-10 (Fig. 3A), an
interferon-inducible protein, which has chemotactic activity for
Fig. 1. Immunofluorescence of hMPV-infected human airway epithelial cells. Normal bronchial epithelial cells (NHBE, A), small airway epithelial cell (SAE, B) and
human alveolar type II-like epithelial cell line (A549, C) were infected with hMPVat MOI 3 for 48 h and stained with an anti-hMPV polyclonal antibody (left panel) or
isotype antibody (right panel). Cells were analyzed using a Zeiss LSM 510 meta-ultraviolet laser scan confocal microscope for panels A and B or fluorescent
microcopy for panel C. No staining was observed in mock-infected cells when similar staining was done (data not shown).
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role in limiting viral replication in other infection models
(Dufour et al., 2002). IP-10 was secreted in significant amounts
from infected epithelial cells starting at 12 h p.i., peaking at 24 h
p.i. and declining at 48 h p.i. Among the CC chemokines,
hMPV significantly induced the secretion of MCP-1 (Fig. 3B), aTable 1
hMPV replication in primary airway epithelial cells and cell lines





LLC-MK2 8.5×105monocyte chemoattractant protein (Rollins et al., 1990). The
secretion pattern and intensity of MCP-1 from infected cells
were similar to those of IP-10, although the basal level of MCP-
1 was higher than that of IP-10. Regarding macrophage
inflammatory protein 1α (MIP-1α), the secretion of control
cells was under the detection limit (4 pg/ml) at all time points.
Unlike the secretion of the other chemokines, MIP-1α secretion
from hMPV-infected cells was not striking, only around 35 pg/
ml at 24 h p.i and 40 pg/ml at 48 h p.i. respectively (Fig. 3C),
which is consistent with our previous observation of low MIP-
1α secretion in bronchoalveolar lavage of hMPV-infected mice
(Guerrero-Plata et al., 2005b). The secretion patterns and
intensity of MIP-1β were very similar to those of MIP-1α (data
not shown). Among the tested cytokines, hMPV infection
resulted in significant induction of IL-6 in A549 cells (Fig. 3D).
Fig. 2. Chemokines induced by hMPV in A549 and SAE cells. A549 and SAE cells were infected with hMPVat MOI of 3 for various lengths of time. Secretion of IL-8
(A) and RANTES (B) by hMPV-infected A549 and SAE cells was assayed by ELISA. Data are expressed as mean±standard error of two independent experiments
performed in triplicates.
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IL-8 and RANTES (Fig. 2).
hMPV infection activates transcription factors of the NF-κB
and IRF families
In previous studies we have characterized the mechanisms
involved in RSV-induced expression of the chemokines IL-8
and RANTES. Both chemokines are dependent on an intact NF-
κB signaling pathway for their transcription, as we and others
have previously shown (Garofalo et al., 1996; Casola et al.,
2001b; Tian et al., 2002). RSV-induced RANTES expression is
also dependent on the activation of IRF proteins which are
absolutely necessary for RANTES promoter induction (Gar-
ofalo et al., 1996; Casola et al., 2001b). NF-κB is a superfamily
of ubiquitous transcription factors composed of NF-κB1 or p50,
NF-κB2 or p52, RelA or p65, RelB and c-Rel proteins, which
can form homo- and heterodimers and produce complexes with
various transcriptional activities. Their activation is partly
controlled by accessory inhibitory proteins called IκBs (Beg
and Baldwin, 1993). NF-κB inducing stimuli cause IκB
phosphorylation, through activation of the multicomponent
IκB kinase (IKK) complex (Karin and Delhase, 2000), with
subsequent IκB proteolytic degradation (Henkel et al., 1993),event that allows NF-κB to enter the nucleus and activate target
genes. To determine whether hMPV infection produced changes
in abundance of DNA-binding proteins that recognized the NF-
κB binding site of the IL-8 gene promoter, we initially used gel
mobility shift assays (EMSA). As shown in Fig. 4A, a single
nucleoprotein complex (C3) was formed from nuclear extracts
of control cells on the NF-κB probe, while two other
complexes, C1 and C2, were faintly detected. hMPV infection
markedly increased the binding of C1 and C2 starting at 6 h p.i.,
with maximal binding intensity at 24 h p.i. We have previously
shown, in the contest of RSV infection, that C2 is constituted by
a p50–p65 heterodimer and C1 represents a p65 homodimer
(Garofalo et al., 1996). To determine the mechanism for
enhanced NF-κB binding activity, we performed Western blot
analysis of p50 and p65 using nuclear extracts from control and
hMPV-infected A549 cells (Fig. 4B). Both proteins were
detected in the nuclear compartment of uninfected cells.
However, upon hMPV infection, a time-dependent increase in
p50 and p65 was observed, starting between 3 and 6 h p.i., with
maximal nuclear translocation detected at 24 h p.i. The time-
dependent increase in nuclear p50 and p65 was parallel to the
changes in DNA-binding activity observed in EMSA.
IRF transcription factors have been shown to play a
fundamental role in the induction of several genes involved in
Fig. 3. Cytokine and chemokine production by A549 cells infected with hMPV. A549 cells were infected with hMPVat MOI of 3. Cell supernatants were collected at
different time points of infection and tested for cytokines and chemokine secretion by multiplex bead assay. Data are expressed as mean±standard error of two
independent experiments performed in triplicates. Open bars represent uninfected and solid bars hMPV-infected cells.
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type I IFNs, chemokines and cytokines, like IL-15. Activation of
IRFs is stimulus- and cell type-dependent. Among all members
of the IRF family, IRF-1, IRF-3 and IRF-7 are the ones best
characterized. IRF-1 and IRF-7 are inducible proteins, while
IRF-3 is constitutively expressed. IRF-3 and -7 are phosphory-
lated on several serine/threonine residues, upon viral infection.
This event allows dimerization, nuclear localization and DNA
binding (Taniguchi et al., 2001). To determine whether hMPV
infection produced changes in the abundance of DNA-binding
proteins recognizing the ISRE (interferon-stimulated response
element) of the RANTES gene promoter, we performed EMSA
similar to the one described for NF-κB.As shown in Fig. 5A, one
inducible nucleoprotein complex was formed on the ISRE
probe, starting at 6 h p.i. We have previously shown that, in
response to RSV infection, IRF-1, -3 and -7 all bind to the
RANTES ISRE (Casola et al., 2001b). To determine whether
hMPV infection induced a similar activation of the IRF proteins,
we performed Western blot analysis of IRF-1, -3 and -7 using
nuclear extracts from control and hMPV-infected A549 cells
(Fig. 5B). We found increased IRF-3 nuclear translocation
starting around 6 h p.i., while IRF-1 and -7 appeared later,
around 12 h p.i. Altogether, these data suggest that both NF-κBand IRF proteins are activated in airway epithelial cells in
response to hMPVinfection, and they are likely to play a key role
in regulating proinflammatory gene expression.
hMPV induces type I interferon production and activates
interferon-dependent signaling pathways in airway epithelial
cells
Interferons (IFNs) are a superfamily of cytokines with anti-
viral, as well as anti-proliferative and immunomodulatory
functions (Smith et al., 2005). Type I IFNs, which include
IFN-α, -β and -λ, are the first line of defense against viral
infections. As IFNs play an essential role in limiting virus
replication, we determined whether hMPV was able to induce
type I IFN production in airway epithelial cells. A549 cells were
infected with hMPV, MOI of 3, and cell supernatants were
harvested at different time points of infection to measure IFN-α
and -β byELISA.We found that both IFN-α and -βwere induced
by hMPV infection of A549 cells in a time-dependent manner
(Fig. 6), with a more significant induction of IFN-β than IFN-α.
IFN-β gene expression is a primary cellular response to viral
infection and depends on activation of the transcription factors
NF-κB and IRF-3 (Hiscott et al., 1999), constitutively expressed
Fig. 5. IRF activation induced by hMPV infection in A549 cells. (A) Nuclear
extracts were prepared from A549 cells control and infected with hMPV, MOI of
3, for 6, 12, 24 and 48 h and used for binding to the RANTES ISRE probe in
EMSA. Shown is the inducible nucleoprotein complex formed on the probe in
response to the infection. UV indicates UV-inactivated virus. (B) Western blot of
IRF-1, -3 and -7 in A549 cells infected with hMPV. Nuclear proteins were
prepared from control and A549 cells infected for various lengths of time,
fractionated on a 10% SDS–PAGE, transferred to PVDFmembranes and probed
with the appropriate antibody. Lamin b was used as an internal control to
determine equal loading of the samples.
Fig. 4. NF-κB activation in response to hMPV infection in A549 cells.
(A) Nuclear extracts were prepared from A549 cells control and infected with
hMPV, MOI of 3, for 6, 12, 24 and 48 h and used for binding to the IL-8 NF-κB
probe in EMSA. Shown are the nucleoprotein complexes formed on the probe in
control cells and in response to the infection. C1 and C2 are hMPV-inducible
complexes, while C3 is constitutive. UV indicates UV-inactivated virus.
(B) Western blot of p50 and p65 in hMPV-infected cells. Nuclear proteins were
prepared from control and A549 cells infected for various lengths of time,
fractionated on a 10% SDS–PAGE, transferred to PVDFmembranes and probed
with the appropriate antibody. Lamin b was used as an internal control to
determine equal loading of the samples.
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STAT1 and STAT2, which, together with IRF-9, form the ISGF3
complex, responsible for the expression of a variety of
interferon stimulated genes (ISGs), including IRF-7, which is
required for IFN-α gene expression (Sato et al., 2000). STAT
proteins are constitutively expressed and located in the
cytoplasm of unstimulated cells. Upon activation, they are
phosphorylated on specific tyrosine residues, post-translational
modifications necessary for dimerization, nuclear translocation
and DNA binding (reviewed in Imada and Leonard, 2000). To
determine whether hMPV infection of A549 cells induced
activation of STAT1, STAT2 and IRF-9, we performed Western
blot analysis of nuclear proteins extracted from A549 cells
uninfected or infected for various lengths of time. As shown in
Fig. 7, hMPV infection induced a time-dependent increase in
tyrosine phosphorylation and nuclear translocation of STAT1,
starting around 6 h p.i. It also induced increased nuclear
translocation of STAT2 and IRF-9 between 6 and 12 h p.i.,
indicating that hMPV can activate the ISGF3 complex
necessary to mediate interferon-dependent cellular responses,
in particular antiviral gene expression.
Discussion
Human metapneumovirus has been identified as a major
viral pathogen, causing both upper and lower respiratory tract
infections. Many children with a LRTI have a clinical syndromeconsistent with bronchiolitis, with fever, cough, tachypnea,
wheezing, and hypoxia (Boivin et al., 2002; Esper et al., 2003;
Falsey et al., 2003). Chest radiographs demonstrate focal
infiltrates and peribronchial cuffing (Esper et al., 2003).
Although the mechanisms mediating hMPV-induced lung
disease are largely unknown, airway inflammation is likely to
play a major role, as suggested by the recently developed small
animal models of infection (Hamelin et al., 2006b; Williams et
al., 2005; Guerrero-Plata et al., 2005b). Both in mice and cotton
rats, hMPV infection induces significant lung inflammation and
treatment with a combination of steroids and ribavirin, which
affects hMPV replication, induces a significant reduction in
lung pathology and disease (Hamelin et al., 2006a). Airway
epithelial cells represent the major target of respiratory viruses
and they are able to synthesize and secrete soluble mediators,
upon injury or infection, which are important for the recruitment
and activation of immune/inflammatory cells (reviewed in
Lemanske, 1992). In this study, we show that hMPV can infect
and replicate similarly both in normal airway epithelial cells,
isolated from different tracts of the airways, as well as in cell
lines. Replication of hMPV induces a variety of cytokines and
chemokines, whose expression is dependent on viral replica-
tion. The finding that hMPV can induce IL-8 and RANTES
secretion in SAE and A549 cells in a similar manner suggests
that A549 cells can be used as an in vitro model of hMPV lower
respiratory tract infection. We have previously shown that SAE
cells display a similar profile of chemokine/cytokine gene
Fig. 6. Type I IFN production by airway epithelial cells infected with hMPV. A549 cells were infected with hMPVat MOI of 3. Cell supernatants were collected at 6,
12, 24 and 48 h p.i. and tested for type I interferon production by ELISA. Data are expressed as mean±standard error of two independent experiments performed in
triplicates. Open bars represent uninfected and solid bars hMPV-infected cells.
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tion compared to A549 cells, following infection with res-
piratory syncytial virus (RSV), another member of the
paramyxovirus family and the number one cause of viral
lower respiratory tract infections in children (Garofalo et al.,
1996; Olszewska-Pazdrak et al., 1998; Casola et al., 2001a;
Zhang et al., 2001; Pazdrak et al., 2002).
In this study, we found that hMPV is a strong inducer of both
CXC and CC chemokines, as well as of proinflammatory
cytokines such as IL-6. While IL-8 secretion was detectable at
6 h p.i., induction of other chemokines, including IP-10, MCP-1
and RANTES, was significant starting at 15 h p.i. IL-8 is the
prototype of ELR-containing CXC chemokines, which recruit
and activate neutrophils. We and others have shown that hMPV
induces CXC chemokine production in a mouse model of
infection, in which neutrophils are the prominent cell type seen
in early airway inflammation (Hamelin et al., 2005; Guerrero-
Plata et al., 2005b). Furthermore, significant levels of IL-8 have
been detected in respiratory secretions of hMPV-infectedFig. 7. ISGF3 complex activation in response to hMPV infection. A549 cells
were infected with hMPV, MOI of 3, for 6, 12 and 24 h. Cells were harvested to
prepare nuclear extracts and equal amounts of protein from control and infected
cells were assayed for phosphorylated and total STAT1, total STAT2 and IRF-9
byWestern blot. Lamin b was used as internal control to determine equal loading
of the samples.children with bronchiolitis (Jartti et al., 2002; Laham et al.,
2004).
Mononuclear cells, including macrophages/monocytes and
lymphocytes, represent also an important component of the lung
inflammatory infiltrate present in animal models of hMPV
infection (Hamelin et al., 2005). Among the non-ELR-contain-
ing CXC chemokines, hMPV induced the expression of IP-10,
which is an interferon-inducible protein and has been shown to
play an important role in limiting viral replication in other
infection models (Dufour et al., 2002; Hamilton et al., 2004).
Among the CC chemokines, hMPV induced the expression of
RANTES, MCP-1 and MIP-1α/β. These molecules have been
shown to activate a variety of cell types, including monocytes,
T-lymphocytes, eosinophils, basophils and dendritic cells,
which are likely to play a significant role in the pathogenesis
of hMPV-induced inflammatory lung disease, as well as in the
modulation of immune responses, as it has been previously
shown in RSV and other models of respiratory viral infections
(Haeberle et al., 2001; Bonville et al., 2004; Domachowske et
al., 2000). In comparison to RSV, hMPV infection displayed a
delayed kinetics and lower induction of chemokines in airway
epithelial cells (Olszewska-Pazdrak et al., 1998; data not
shown), in particular for MIP-1α and -1β secretion, which
could be due to hMPV slower viral replication and lower viral
titers achieved in A549 cells (RSV titer in A549 cells at 24 h is
similar to the hMPV titer at 72 h p.i. and it is ten fold higher at
later time points, data not shown). A lower chemokine and
cytokine induction by hMPV, compared to RSV, was also
observed in dendritic cells, as well as in a mouse model of
infection and in children (Guerrero-Plata et al., 2006, 2005b;
Laham et al., 2004).
Proinflammatory cytokines, such as IL-1, IL-6 and TNF,
have been implicated in the pathogenesis of paramyxovirus-
induced lung disease (reviewed in Graham et al., 2000 and
Garofalo and Haeberle, 2000). We did not detect significant
production of IL-1 and TNF, but there was a significant
secretion of IL-6 in response to hMPV infection. IL-6 pro-
duction has been previously observed both in an animal model
of hMPV infection and in infected children (Guerrero-Plata et
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cytokines play a role in hMPV-induced lung inflammation and
disease pathogenesis will require further investigations.
Different patterns of inflammatory mediator secretion in
response to RSV and hMPV infection may be also caused by
different activation of intracellular signaling pathways and
subsequent different induction of transcription factors by the
two viruses. To start to address this question, we investigated
two of the key transcription factors involved in proinflamma-
tory gene expression, NF-κB and IRF proteins. Our results
show that hMPV is a strong inducer of both p50 and p65,
belonging to the NF-κB family, as well as of IRF-1, -3 and -7.
hMPV infection of A549 cells induced nuclear translocation of
these proteins and increased binding to their specific DNA-
binding sites present in the IL-8 and RANTES gene promoters.
We have previously shown that RSV infection of A549 cells is a
potent activator of p65/RelA, which is absolutely required for
RSV-inducible IL-8 gene transcription (Garofalo et al., 1996).
We have also shown that RSV infection of A549 cells induces
IRF-1 synthesis, nuclear translocation and binding to a newly
identified responsive element of IL-8 promoter involved in
RSV-induced IL-8 transcription (Casola et al., 2000). IRF-7
synthesis is also induced in RSV-infected A549 cells, while
IRF-3 is constitutive, and in alveolar epithelial cells IRF-1, -3
and -7 are the IRF proteins necessary for RSV-induced
RANTES promoter activation (Casola et al., 2001a). Therefore,
it is likely that both NF-κB and IRF play a critical role in
cytokine and chemokine gene expression in response also to
hMPV infection.
Different from RSV, we found that hMPV induced IFN-α
secretion in infected A549 cells. This result is consistent with
our previous observation in monocyte-derived dendritic cells, as
well as in a mouse model of infection, in which hMPV, but not
RSV infection, induces significant production of IFN-α
(Guerrero-Plata et al., 2006, 2005b). RSV failure to induce
IFN-α production in A549 cells has been previously reported
(Spann et al., 2004). Two RSV nonstructural proteins, NS1 and
NS2, have been shown to partially inhibit activation of NF-κB
and IRF-3 and disrupt STAT-2-mediated signaling pathway,
which is important for type I IFN-mediated signaling, including
IFN-α production and expression of antiviral genes (Spann et
al., 2005; Ramaswamy et al., 2006; Wright et al., 2006).
Compared to RSV, hMPV does not have NS1 and NS2, and this
could explain hMPVability to induce higher levels of both IFN-
α and -β in epithelial, as well as non-epithelial cells. However,
we have also reported that hMPV, similar to RSV, can inhibit
Toll-like receptor (TLR)-dependent type I IFN production
(Guerrero-Plata et al., 2005a). This observation, together with
the finding that the amount of IFN-α secreted by hMPV-
infected A549 cells is much less than that secreted by
monocyte-derived dendritic cells, would suggest that hMPV
also might have evolved strategies to modulate interferon
production and interferon-dependent signaling pathways.
Which viral protein(s) is responsible for this activity remains
to be investigated.
In summary, in this study we have started to characterize the
airway epithelial cell responses to hMPV, an importantrespiratory pathogen. As the airway epithelium is the primary
target of hMPV infection, the identification of genes and
pathways activated by this respiratory virus is highly relevant




The following reagents were purchased from the indicated
suppliers: Eagle's minimal essential medium, F12K medium,
L-glutamine, penicillin–streptomycin–amphotericin B (Gibcol,
Carlsbad, CA); LLC-MK2 cells (Rhesus monkey kidney
ATCC CCL-7) and human alveolar type II-like epithelial
cells (A549 cells) (ATCC; Manassas, VA); small alveolar
epithelial cells (SAE) and normal bronchial epithelial cells
(NHBE) (Clonetics, San Diego, CA); double antibody ELISA
kit (Duo-Set, R&D Systems, Minneapolis, MN); antibodies
for IRFs, p50 and lamin B (Santa Cruz, Santa Cruz, CA);
antibody for p65 (Upstate, Charlottesville, VA); radioactive
probe (Du Pont NEN Research Products, Boston, MA); human
interferon-α and -β ELISA kit (PBL Biomedical Laboratories,
Piscataway, NJ); Bio-Plex Human Cytokine panel (Bio-Rad
Laboratories, Hercules, CA).
Cell culture and viral preparation
LLC-MK2 cells were maintained in MEM supplemented
with 10% fetal bovine serum (FBS), penicillin and streptomycin
(100 U/ml). A549 cells were maintained in F12K medium
containing 10% (v/v) FBS, 10 mM glutamine, 100 IU/ml
penicillin and 100 μg/ml streptomycin. Primary cultured SAE
and NHBE cells were grown according to the company
instructions. For most experiments, confluent cells were
infected with hMPV in serum-free media with 1.0 μg trypsin/
ml at MOI 3 to 5. Viral stocks were obtained by infecting LLC-
MK2 cells at MOI 0.1. Around day 5 post-infection, cells were
disrupted using glass beads and then scraped completely from
the flasks. Total medium was collected and sonicated on ice for
5 min. The preparation was then vortexed and centrifuged at
2900×g for 15 min on ice. Crude virus was collected and then
purified on a sucrose cushion. Viral titers were determined by
immunostaining, as previously described (Guerrero-Plata et al.,
2006).
Immunofluorescence
Replication of hMPV in NHBE, SAE and A549 cells was
verified by immunochemistry staining using anti-hMPV poly-
clonal antibody (a gift from MedImmune Inc., Gaithersburg,
MD). Cells were plated in a slide chamber and infected with
hMPV using MOI of 3 for 24 h. Cells were washed with PBS
and fixed with 1% paraformaldehyde at room temperature for
15 min. Cells were then washed with PBS twice followed by
incubation with 0.2% Triton 100-X. Following PBS washes,
slides were incubated with a primary guinea pig isotype control
99X. Bao et al. / Virology 368 (2007) 91–101Ab or anti-hMPV antibody (1:200) for 1 h. Cells were washed
again and incubated with a secondary FITC-conjugated anti-
guinea pig antibody. Picture was taken using Zeiss LSM Image
Browser software v. 3.0 (Zeiss, Thornwood, NY).
Bio-Plex
Chemokines and cytokines (IL-1RA, IL-1β, IL-2, IL-4, IL-5,
IL-6, IL-7, IL-9, IL-10, IL-12 p70, IL-13, IL-17, G-CSF, GM-
CSF, IFN-γ, IP-10, EOTAXIN, MIP-1α, MIP-1β, GCSF,
FGFB, PDGF, VEGF and TNF-α) were quantified by the
Luminex-based Bio-Plex system (Bio-Rad Laboratories, Her-
cules, CA) according to the manufacturer's instructions. The
lower limit of detection for all cytokines measured by Bio-Plex
is 3 pg/ml.
ELISA
Human IL-8 and RANTES concentrations in cell culture
supernatants were determined using DuoSet ELISA kits (R&D,
Systems Minneapolis, MN). IFN-α and -β were determined by
human interferon-α and -β ELISA kit (lower limit of detection,
12.5 pg/ml, PBL Biomedical Laboratories, Piscataway, NJ)
according to manufacturer's instructions.
EMSA
Nuclear extracts of uninfected and infected cells were
prepared using hypotonic/nonionic detergent lysis, according
to Schaffner protocol (Schreiber et al., 1989). To prevent
contamination with cytoplasmic proteins, isolated nuclei were
purified by centrifugation through 1.7 M sucrose buffer A for
30 min, at 12,000 rpm, before nuclear protein extraction, as
previously described (Brasier et al., 2004). After normalization,
nuclear proteins were used to bind to duplex oligonucleotides
corresponding to either the RANTES ISRE or the IL-8 NF-κB
binding sites, as previously described (Casola et al., 2001b,
2000). DNA-binding reactions contained 10–15 μg nuclear
proteins, 5% glycerol, 12 mM HEPES, 80 mM NaCl, 5 mM
DTT, 5 mM Mg2Cl, 0.5 mM EDTA, 1 μg of poly dI–dC, and
40,000 cpm of 32P-labeled double-stranded oligonucleotide in a
total volume of 20 μl. The nuclear proteins were incubated with
the probe for 15 min at room temperature and then fractionated
by 6% nondenaturing polyacrylamide gels (PAGE) in TBE
buffer (22 mM Tris–HCl, 22 mM boric acid, 0.25 mM EDTA,
pH 8). After electrophoretic separation, gels were dried and
exposed for autoradiography using Kodak XAR film at −70 °C
using intensifying screens.
Western blot analysis
Nuclear extracts were prepared as described above. Proteins
(10 to 30 μg per sample) were then boiled in 2× Laemmli buffer
for 2 min and resolved on SDS–PAGE. Proteins were
transferred to polyvinylidene difluoride membranes (Bio-
Rad). Nonspecific binding sites were blocked by immersing
the membrane in TBST blocking solution [10 mM Tris–HCl,pH 7.6, 150 mM NaCl, 0.05% Tween-20 (v/v)] containing 5%
skim milk powder or 5% bovine serum albumin for 30 min.
After a short wash in TBST, the membranes were incubated
with the primary antibody for 1 h followed by an anti-rabbit
peroxidase-conjugated secondary antibody (Santa Cruz Bio-
technology), diluted 1:10,000 in TBST for 30 min. After
washing, the proteins were detected by autoradiography using
ECL regular or plus (Amersham Pharmacia Biotech) according
to manufacturer's protocol. Equal loading of proteins was
evaluated by stripping and reprobing the membranes with anti-
lamin B antibody.
Statistical analysis
Statistical significance was analyzed by using analysis of
variance (ANOVA). P value of less than 0.05 was considered
significant. Mean±SEM is shown.
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